Can Sanofi And GSK Catch Up In mRNA Vaccines?
Pfizer And Moderna Have Head Start
GSK and Sanofi have little chance of making a big impact in COVID-19 vaccines, but hope to establish themselves in the technology in key markets such as flu.
GSK and Sanofi have little chance of making a big impact in COVID-19 vaccines, but hope to establish themselves in the technology in key markets such as flu.